Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05983159
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:23.998703+00:00
Published At
2026-02-19T00:00:00+00:00
Record Updated At
2026-02-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Slow-Flow Vascular Malformation", "Fast-Flow Vascular Malformation", "Vascular Malformations", "Venous Malformation", "Lymphatic Malformation, Low Flow", "Lymphatic Malformation", "Lymphangioma", "Arteriovenous Malformations", "Venous Malformation, Low Flow", "Cystic Hygroma", "Vascular Anomaly", "Vascular Anomalies", "PI3K Gene Mutation", "MAP2K1 Gene Mutation", "PIK3CA-related Overgrowth Spectrum", "Arteriovenous Malformation (AVM)", "KRAS G12C", "KRAS G12D"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-19"
protocolSection.identificationModule.nctId
"NCT05983159"
protocolSection.identificationModule.officialTitle
"A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Slow-Flow Vascular Malformation (protocolSection.conditionsModule.conditions)
  • Fast-Flow Vascular Malformation (protocolSection.conditionsModule.conditions)
  • Vascular Malformations (protocolSection.conditionsModule.conditions)
  • Venous Malformation (protocolSection.conditionsModule.conditions)
  • Lymphatic Malformation, Low Flow (protocolSection.conditionsModule.conditions)
  • Lymphatic Malformation (protocolSection.conditionsModule.conditions)
  • Lymphangioma (protocolSection.conditionsModule.conditions)
  • Arteriovenous Malformations (protocolSection.conditionsModule.conditions)
  • Venous Malformation, Low Flow (protocolSection.conditionsModule.conditions)
  • Cystic Hygroma (protocolSection.conditionsModule.conditions)
  • Vascular Anomaly (protocolSection.conditionsModule.conditions)
  • Vascular Anomalies (protocolSection.conditionsModule.conditions)
  • PI3K Gene Mutation (protocolSection.conditionsModule.conditions)
  • MAP2K1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • PIK3CA-related Overgrowth Spectrum (protocolSection.conditionsModule.conditions)
  • Arteriovenous Malformation (AVM) (protocolSection.conditionsModule.conditions)
  • KRAS G12C (protocolSection.conditionsModule.conditions)
  • KRAS G12D (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.